Prestige Consumer Healthcare Inc.
corporate_fare Company Profile
Prestige Consumer Healthcare Inc. (NYSE:PBH) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 20 items for PBH at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for PBH spans 10-Q, 8-K, 8-K/A, 10-K.
Recent high-impact activity:
- Prestige Consumer Posts $1.13 Adjusted EPS for Fiscal Q2
- Prestige Guides FY27 Sales to $1.28B-$1.29B as Clear Eyes Supply Constraints Weigh
- Prestige Consumer Healthcare Q1 FY2027: Revenue Climbs 6.5% on Breathe Right, but Integration Costs Weigh on Margins
- Prestige Consumer Healthcare Tops Q1 Estimates and Lifts FY27 Guidance, Fueled by Acquisitions
- Prestige Consumer Healthcare Raises FY27 Outlook to Include Acquisitions
Financial Snapshot
Short Interest & Short Volume
8.05 days to coverFINRA reported short interest of 4,243,261 shares in PBH as of the October 30, 2026 settlement, a 7.1% increase from the prior period — about 8.1 days to cover at its recent average daily volume. On November 20, 2026, 51.6% of PBH volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.